ClinicalTrials.Veeva

Menu
I

Intercoastal Medical Group | Clinical Research

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

LY3002813
Donanemab
Semaglutide
ENT-01
Bococizumab
Gantenerumab
GV-971
Mevidalen
Ziltivekimab
Seltorexant

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

7 of 32 total trials

A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE Plus)

This study is done to find out whether the medicine, semaglutide, has a positive effect on early Alzheimer's disease.Participants will either get sem...

Active, not recruiting
Early Alzheimer´s Disease
Drug: Placebo (semaglutide)
Drug: Semaglutide

This study is done to find out whether the medicine, semaglutide, has a positive effect on early Alzheimer's disease.Participants will either get sem...

Active, not recruiting
Early Alzheimer's Disease
Drug: Placebo (semaglutide)
Drug: Semagludtide

The reason for this study is to see how safe and effective the study drug donanemab is in participants with early Alzheimer's disease.Additional part...

Active, not recruiting
Alzheimer Disease
Drug: Donanemab
Drug: Placebo

The main purpose of this study is to look at how safe the study drug (mevidalen) is and whether it works to alleviate symptoms when given to people w...

Enrolling
Alzheimer Disease
Drug: Placebo
Drug: Mevidalen

The research study is being done to see if ziltivekimab can be used to treat people who were admitted to hospital because of a heart attack. Ziltivek...

Enrolling
Acute Myocardial Infarction (AMI)
Cardiovascular Risk
Drug: Ziltivekimab
Drug: Placebo
Locations recently updated

Extensive research is being conducted in search of neuroprotective agents for possible use in the acute phase of stroke and agents that can be used f...

Enrolling
Cerebral Stroke
Acute Ischemic Stroke
Drug: Drug: Normal Saline
Drug: Sovateltide

The primary objective of this trial is to demonstrate that maridebart cafraglutide is superior to placebo when given as an adjunct to standard of car...

Enrolling
Overweight
Atherosclerotic Cardiovascular Disease
Drug: Maridebart Cafraglutide
Drug: Placebo

Trial sponsors

Lilly logo
Novo Nordisk logo
Amgen logo
Eisai logo
E
Pfizer logo
Roche logo
AstraZeneca logo
Boston Scientific logo
B

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems